Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

Completed · Phase 1

Conditions studied: Drug Interaction

In brief

This is a single center, open-label, fixed sequence, drug-drug interaction (DDI) study in healthy subjects.

Key facts

Study ID
NCT04902105
Run by
Emalex Biosciences Inc.
People needed
38
Starts
2021-05-13
Expected to finish
2021-07-06
Last updated by the study team
2021-07-22

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.